~~<i id='433AF9384E'><strike id='433AF9384E'><tt id='433AF9384E'><pre id='433AF9384E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：knowledge 2025-10-01 21:33:39 - browse：7

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Hospitals are piloting generative AI tools as regulators play catch

Wikipedia

focus

entertainment

Wikipedia

leisure time

AdobeRingTherapeutics,agenetherapystartuplaunchedbyFlagshipPioneering,haslaidoffjustunder20%ofitssta

WSS

Winning ticket for $1 billion Powerball jackpot sold in California

Tesla recalling nearly 16,000 of its 2021

Driven by the pandemic, applicants flood public health schools

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Indian pharmaceutical industry in denial over drug

Vir antibody drug aimed at influenza A fails in clinical trial

focus

hotspot

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Weight loss drugs aren’t covered by Obamacare. That may change

Medical leaders decry Supreme Court decision on affirmative action

Congress may force more Covid

In Memoriam: Notable people who died in 2023

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Drug repurposing or repositioning? The language matters

Flagship Pioneering startup Sonata Therapeutics lays off 21

Duchenne breakthrough therapy leaves behind pioneering families

Congress may force more Covid

focus

MD Anderson's Padmanee Sharma responds to research credit suit

Tocagen's brain cancer gene therapy trial continues. Investors worry

Judge rejects Trump's request to move Stormy Daniels hush

Ending racial health disparities hinges on penalties, political will

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

I learned firsthand about improving diversity in clinical trials

focus

entertainment

Wikipedia

leisure time